Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation
TechCrunch
Read Full Article at TechCrunch →Ad Slot — In-Article (728x90)
The de-extinction startup is looking to double or triple its previous valuation, according to the report.
This is a summary. For the full story, read the original article at TechCrunch.
Original source: TechCrunch